Abstract

  Antimicrobial resistance is now a major challenge to clinicians for treating patients. Multidrug resistance (MDR) bacteria or super bugs are one of the most important current threats to public health. Typically, MDR bacteria are associated with nosocomial infections. The spread of multidrug resistance bacteria into the community is associated with increased morbidity, mortality and health care costs. Methicillin resistance Staphylococcus aureus (MRSA) is the most prevalent of MDR bacteria. Others are Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Klebsiella pneumoniae and E. coli. Antibiotic resistance accounts for about 70,000 deaths per year worldwide and is projected to be 10 million in 2050. It is estimated that nearly half of the people aged 15 to 24 years taken antibiotics which was not meant for them. Considering this, a study was conducted to know the pattern of causative superbugs and their antimicrobial sensitivity.

Keywords: Superbugs; MDR Bacteria; MRSA; Amies Transport Medium; Antibiotic Sensitivity

References

1. National treatment guidelines for Antimicrobial use in infectious diseases, version1.0 (2016).
2. National action plan on Antimicrobial Resistance (co-ordinated by Ministry of Health and Family welfare, Government of India).
3. Hospital infection prevention and control guidelines.
4. Mark Honigsbaum. “Superbugs and us”. The Lancet10119 (2018): P420.
5. Jyoti Tanwar., et al. “Multidrug resistance: An emergency crisis”. Interdisciplinary Perspectives on Infectious Diseases (2014): 541340.
6. Oechslin Frank and Oechslin Frank. "Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy". Viruses7 (2018): 351.
7. Hussain T. “Pakistan at the verge of potential epidemics by multi-drug resistant pathogenic bacteria”. Advancements in Life Sciences 2 (2015): 46-47.
8. Stix G. "An antibiotic resistance fighter". Scientific American 4 (2006): 80.
9. Bennett PM. "Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria". British Journal of Pharmacology 1 (2008): S347-S357.

Citation

Citation: Brajpal Singh Tyagi and Mamatarani Rout. “An Initiative to Prevent Emergent Super Bugs in ENT Practice". Acta Scientific Otolaryngology 2.5 (2020): 09-11.

Copyright

Copyright: © 2020 Brajpal Singh Tyagi and Mamatarani Rout. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.